» Articles » PMID: 32110860

Danegaptide Enhances Astrocyte Gap Junctional Coupling and Reduces Ischemic Reperfusion Brain Injury in Mice

Overview
Journal Biomolecules
Publisher MDPI
Date 2020 Mar 1
PMID 32110860
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Ischemic stroke is a complex and devastating event characterized by cell death resulting from a transient or permanent arterial occlusion. Astrocytic connexin43 (Cx43) gap junction (GJ) proteins have been reported to impact neuronal survival in ischemic conditions. Consequently, Cx43 could be a potential target for therapeutic approaches to stroke. We examined the effect of danegaptide (ZP1609), an antiarrhythmic dipeptide that specifically enhances GJ conductance, in two different rodent stroke models. In this study, danegaptide increased astrocytic Cx43 coupling with no significant effects on Cx43 hemichannel activity, in vitro. Using matrix-assisted laser desorption ionization imaging mass spectrometry (MALDI IMS) the presence of danegaptide within brain tissue sections were detected one hour after reperfusion indicating successful transport of the dipeptide across the blood brain barrier. Furthermore, administration of danegaptide in a novel mouse brain ischemia/reperfusion model showed significant decrease in infarct volume. Taken together, this study provides evidence for the therapeutic potential of danegaptide in ischemia/reperfusion stroke.

Citing Articles

Role of Impaired Astrocyte Gap Junction Coupling in Epileptogenesis.

Bedner P, Steinhauser C Cells. 2023; 12(12).

PMID: 37371139 PMC: 10297487. DOI: 10.3390/cells12121669.


Connexin hemichannels as candidate targets for cardioprotective and anti-arrhythmic treatments.

Leybaert L, De Smet M, Lissoni A, Allewaert R, Roderick H, Bultynck G J Clin Invest. 2023; 133(6).

PMID: 36919695 PMC: 10014111. DOI: 10.1172/JCI168117.


Remodeling of the Neurovascular Unit Following Cerebral Ischemia and Hemorrhage.

Sato Y, Falcone-Juengert J, Tominaga T, Su H, Liu J Cells. 2022; 11(18).

PMID: 36139398 PMC: 9496956. DOI: 10.3390/cells11182823.


Connexins Signatures of the Neurovascular Unit and Their Physio-Pathological Functions.

Vicario N, Parenti R Int J Mol Sci. 2022; 23(17).

PMID: 36076908 PMC: 9455936. DOI: 10.3390/ijms23179510.


Mass Spectrometry Imaging as a New Method: To Reveal the Pathogenesis and the Mechanism of Traditional Medicine in Cerebral Ischemia.

Liang Y, Feng Q, Wang Z Front Pharmacol. 2022; 13:887050.

PMID: 35721195 PMC: 9204101. DOI: 10.3389/fphar.2022.887050.


References
1.
Chen B, Yang L, Chen J, Chen Y, Zhang L, Wang L . Inhibition of Connexin43 hemichannels with Gap19 protects cerebral ischemia/reperfusion injury via the JAK2/STAT3 pathway in mice. Brain Res Bull. 2018; 146:124-135. DOI: 10.1016/j.brainresbull.2018.12.009. View

2.
Laurent G, Leong-Poi H, Mangat I, Moe G, Hu X, So P . Effects of chronic gap junction conduction-enhancing antiarrhythmic peptide GAP-134 administration on experimental atrial fibrillation in dogs. Circ Arrhythm Electrophysiol. 2009; 2(2):171-8. DOI: 10.1161/CIRCEP.108.790212. View

3.
Hansson E, Muyderman H, Leonova J, Allansson L, Sinclair J, Blomstrand F . Astroglia and glutamate in physiology and pathology: aspects on glutamate transport, glutamate-induced cell swelling and gap-junction communication. Neurochem Int. 2000; 37(2-3):317-29. DOI: 10.1016/s0197-0186(00)00033-4. View

4.
Hennan J, Swillo R, Morgan G, Rossman E, Kantrowitz J, Butera J . GAP-134 ([2S,4R]-1-[2-aminoacetyl]4-benzamidopyrrolidine-2-carboxylic acid) prevents spontaneous ventricular arrhythmias and reduces infarct size during myocardial ischemia/reperfusion injury in open-chest dogs. J Cardiovasc Pharmacol Ther. 2009; 14(3):207-14. DOI: 10.1177/1074248409340779. View

5.
Nakase T, Sohl G, Theis M, Willecke K, Naus C . Increased apoptosis and inflammation after focal brain ischemia in mice lacking connexin43 in astrocytes. Am J Pathol. 2004; 164(6):2067-75. PMC: 1615756. DOI: 10.1016/S0002-9440(10)63765-0. View